• Ticker:- PPH;false;MVPPH;
  • Ticker Group:- ETFEQ_IND;false;;
  • Making News

    Benzinga: Interesting Similarities Among 2013's Top-Performing ETFs


    6/18/13: Todd Shriber evaluates the year’s notable ETFs and mentions BBH. He remarks that “biotech ETFs big and small have been stellar performers this year."
    View article » 



    Zacks Equity Research: Semiconductor ETFs for 2013?


    2/07/13: Zacks Equity Research reports that the semiconductor industry is "set to rebound in 2013 with the recovery projected to pick up speed in the latter part of the year" and advises investors to consider SMH as a vehicle for accessing the space.
    View article » 



  • How to Purchase

Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

Pharmaceutical ETF PPH

  • Full Name: Market Vectors®
    Pharmaceutical ETF (PPH)

    Management Style: Replication

    Underlying Index: Market Vectors US Listed Pharmaceutical 25 Index (MVPPHTR)

    Index Description: MVPPHTR is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded pharmaceutical companies.

  •  
     

    • Fund Ticker

      PPH
    • Exchange

      NYSE Arca
    • Index Total Return Ticker

      MVPPHTR
    • Index Provider

      Market Vectors Index Solutions
    • Total Net Assets

      $305.1M
    • Shares Outstanding

      5,438,138
    • Number of Holdings

      26
    • Commencement Date

      12/20/2011
  •  
    as of 06/18/13

  • Portfolio Composition (%)
    as of 06/18/13

    • % of Net Assets

    • Stocks

      100.03
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      -0.03
    • Total

      100.00
  • Download All Holdings All Holdings (%) as of 06/18/13

    Total Holdings: 26
    Holding Name
    Ticker
    Shares Market Value
    (US$)
    % of Net
    Assets
    Johnson & Johnson
    JNJ US
    371,427
    32,076,436 11.90
    Pfizer Inc
    PFE US
    955,236
    28,083,938 10.42
    Novartis AG
    NVS US
    316,422
    23,136,777 8.58
    Merck & Co Inc
    MRK US
    401,588
    19,348,510 7.18
    Sanofi
    SNY US
    306,641
    16,730,333 6.21
    GlaxoSmithKline PLC
    GSK US
    309,671
    16,406,833 6.09
    Bristol-Myers Squibb Co
    BMY US
    294,413
    13,793,249 5.12
    AbbVie Inc
    ABBV US
    294,564
    12,825,317 4.76
    AstraZeneca PLC
    AZN US
    243,047
    12,390,536 4.60
    Abbott Laboratories
    ABT US
    324,383
    12,167,606 4.51
    Teva Pharmaceutical Industries Ltd
    TEVA US
    280,521
    11,119,852 4.13
    Eli Lilly & Co
    LLY US
    201,832
    10,565,905 3.92
    Allergan Inc/United States
    AGN US
    99,731
    10,121,699 3.76
    Novo Nordisk A/S
    NVO US
    62,279
    10,081,102 3.74
    Valeant Pharmaceuticals International I
    VRX US
    97,256
    8,350,400 3.10
    Shire PLC
    SHPG US
    65,195
    6,409,320 2.38
    Watson Pharmaceuticals Inc
    ACT US
    43,957
    5,524,076 2.05
    Mylan Inc/PA
    MYL US
    138,778
    4,422,855 1.64
    Perrigo Co
    PRGO US
    30,849
    3,737,665 1.39
    Forest Laboratories Inc
    FRX US
    82,215
    3,417,678 1.27
    Elan Corp PLC
    ELN US
    171,287
    2,360,335 0.88
    Hospira Inc
    HSP US
    57,970
    2,121,122 0.79
    Warner Chilcott PLC
    WCRX US
    77,370
    1,528,058 0.57
    Endo Pharmaceuticals Holdings Inc
    ENDP US
    38,547
    1,496,395 0.56
    Salix Pharmaceuticals Ltd
    SLXP US
    20,595
    1,376,364 0.51
    Other/Cash
    -87,314 -0.03
    Total (%) 100.03
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.